
Transcarent Secures $126M in Series D Funding
Key Highlights
- $126 million raised in Series D, led by General Catalyst and 7wireVentures, bringing total funding to $450 million.
- The funding round will enhance AI capabilities and support commercial and strategic growth.
- Transcarent’s platform integrates medical, surgery, pharmacy, and mental health care, aiming to simplify healthcare for over 4.3 million people.
Source: Direct
Notable Quotes
Expert Insights
Share Your Expert Insights
Have relevant experience or professional perspective? Add your thoughtful insights to this article.


